Published in

Elsevier, International Journal of Cardiology, (285), p. 1-5, 2019

DOI: 10.1016/j.ijcard.2019.01.037

Links

Tools

Export citation

Search in Google Scholar

The cost-effectiveness of canakinumab for secondary prevention of cardiovascular disease: The Australian healthcare perspective

Journal article published in 2019 by Ella Zomer, Danny Liew ORCID, Andrew Tonkin, James M. Trauer ORCID, Zanfina Ademi ORCID
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Upload
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO